VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RNR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RNRRenaissanceRe Holdings Ltd.
$323.11$13.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRNRFinancials

RenaissanceRe Holdings Ltd. (RNR) Financials

30Y historyFree accessUpdated daily

Revenue growth remains erratic, evidenced by a sharp 36.4% contraction in 2026Q1 following a 117.4% surge in 2024Q3, while underwriting profitability fluctuates significantly with combined ratios ranging from 53.5% to 102.1% over the last two years.

RNR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue11.49B12.75B11.65B9.09B5.05B5.27B5.16B4.18B2.06B2.1B1.73B1.49B1.23B1.36B1.4B1.18B1.24B1.27B1.23B1.67B1.84B1.66B1.57B1.37B913.51M409.67M349.74M270.24M260.53M254.73M295M
Revenue Growth %-8.19%9.45%28.13%80.05%-4.11%2.14%23.37%103.2%-1.87%21.36%15.54%21.12%-9.08%-3.12%18.95%-4.74%-2.7%3.21%-26.08%-9.52%11.16%5.61%14.51%49.89%122.99%17.14%29.42%3.73%2.28%-13.65%-
Medical Costs & Claims4.17B7.57B7.98B5.45B5.91B5.09B3.82B2.86B1.55B2.21B820.15M686.83M342.42M296.79M438.75M958.55M224.31M33.45M974.04M734.2M726.93M1.87B1.34B563.32M410.17M175.28M147.13M102.64M139.26M75.24M113.14M
Medical Cost Ratio %36.33%59.34%68.48%59.93%117%96.69%74.15%68.42%75.52%105.38%47.49%45.95%27.75%21.87%31.32%81.38%18.14%2.63%79.11%44.08%39.49%113.13%85.54%41.14%44.9%42.78%42.07%37.98%53.45%29.54%38.35%
Gross Profit5.12B5.18B3.67B3.64B-858.28M174.46M1.33B1.32B503.46M-112.67M906.72M807.79M891.58M1.06B962.3M219.27M1.01B1.24B257.15M931.35M1.11B-217.34M226.76M805.95M503.35M234.4M202.6M167.59M121.27M179.48M181.85M
Gross Margin %44.57%40.66%31.52%40.07%-17%3.31%25.85%31.58%24.48%-5.38%52.51%54.05%72.25%78.13%68.68%18.62%81.86%97.37%20.89%55.92%60.51%-13.13%14.46%58.86%55.1%57.22%57.93%62.02%46.55%70.46%61.65%
Gross Profit Growth %-41.18%0.79%524.4%-591.98%-86.91%1.01%162.08%546.84%-112.43%12.25%-9.4%-15.93%10.2%338.87%-78.34%-18.2%381.16%-72.39%-16.38%612.47%-195.85%-71.86%60.12%114.74%15.69%20.89%38.2%-32.43%-1.3%-
Operating Expenses1.04B1.17B678.05M532.53M360.55M288.56M336.92M352M240.84M215.51M276.33M311.42M204.72M219.46M195.47M247.72M219.82M181.32M172.43M337.35M315.76M185.87M99.94M101.69M76.56M070.72M64.88M67.17M40.23M-78.05M
OpEx / Revenue %9.02%9.17%5.82%5.86%7.14%5.48%6.54%8.42%11.71%10.28%16%20.84%16.59%16.17%13.95%21.03%17.78%14.27%14.01%20.25%17.15%11.22%6.37%7.43%8.38%0%20.22%24.01%25.78%15.8%-26.46%
Depreciation & Amortization-1.3M2.44M258.46M-134.75M-26.95M-20.99M16.65M-58.96M123K31.24M29.3M18.18M47.77M51.6M59.7M42.3M59.72M9.21M-8.87M-19.77M-12.28M9.63M16.86M13.09M19.04M3.19M315K9.81M14.49M1.12M300K
Combined Ratio %45.35%68.51%74.3%65.79%124.14%102.17%80.68%76.85%87.23%115.66%63.5%66.79%44.34%38.04%45.27%102.42%35.92%16.9%93.12%64.34%56.65%124.35%91.91%48.57%53.28%42.78%62.29%61.99%79.23%45.33%11.9%
Operating Income4.08B4.01B2.99B3.11B-1.22B-114.11M995.92M967.48M262.62M-328.18M630.39M496.38M686.86M841.04M766.84M-28.45M792.36M1.06B84.72M594M798.04M-403.21M126.83M704.26M426.79M234.4M131.88M102.72M54.1M139.25M259.9M
Operating Margin %35.55%31.49%25.7%34.21%-24.14%-2.17%19.32%23.15%12.77%-15.66%36.5%33.21%55.66%61.96%54.73%-2.42%64.08%83.1%6.88%35.66%43.35%-24.35%8.09%51.43%46.72%57.22%37.71%38.01%20.77%54.67%88.1%
Operating Income Growth %-34.11%-3.76%355.17%-968.14%-111.46%2.94%268.4%180.02%-152.06%27%-27.73%-18.33%9.68%2795.58%-103.59%-24.97%1146.43%-85.74%-25.57%297.92%-417.93%-81.99%65.01%82.08%77.74%28.39%89.86%-61.15%-46.42%-
EBITDA4.11B4.02B3.25B2.98B-1.25B-135.1M1.01B908.52M262.74M-296.94M659.69M514.55M734.63M892.63M826.53M13.85M852.08M1.07B75.85M574.23M785.77M-393.58M143.69M717.35M445.83M237.59M132.19M112.53M68.59M140.37M260.2M
EBITDA Margin %35.81%31.51%27.92%32.73%-24.67%-2.57%19.64%21.74%12.78%-14.17%38.2%34.43%59.53%65.77%58.99%1.18%68.91%83.82%6.16%34.48%42.69%-23.77%9.16%52.39%48.8%57.99%37.8%41.64%26.33%55.11%88.2%
Interest Expense125.55M120.85M93.77M73.18M48.34M47.54M50.45M58.36M47.07M44.19M42.14M36.27M17.4M17.93M23.1M23.37M21.83M15.11M24.63M33.63M37.6M28.22M25.97M18.25M13.07M7.25M17.17M9.93M4.47M4.27M6.6M
Non-Operating Income-93.77M-120.85M-93.77M-73.18M-48.34M-47.54M-50.45M-58.36M-47.07M-44.19M-42.14M-36.27M-17.4M-17.93M-23.1M-23.37M-21.83M-15.11M-24.63M-33.63M-37.6M-28.22M-25.97M-18.25M-13.07M47.1M-17.17M-9.93M-4.47M-4.27M97.19M
Pretax Income4.63B4.01B2.99B3.11B-1.22B-114.11M995.92M967.48M262.62M-328.18M630.39M496.38M686.86M841.04M766.84M-28.45M792.36M1.06B84.72M594M798.04M-403.21M126.83M704.26M426.79M180.05M131.88M102.72M54.1M139.25M156.16M
Pretax Margin %40.32%31.49%25.7%34.21%-24.14%-2.17%19.32%23.15%12.77%-15.66%36.5%33.21%55.66%61.96%54.73%-2.42%64.08%83.1%6.88%35.66%43.35%-24.35%8.09%51.43%46.72%43.95%37.71%38.01%20.77%54.67%52.94%
Income Tax408.87M396.33M32.63M-510.07M-59.02M-10.67M2.86M17.21M-6.3M26.49M340K-45.87M608K1.69M1.41M10.38M-6.12M10.03M568K-18.43M935K04M18K-115K14.26M4.65M-1.52M-20.48M00
Effective Tax Rate %8.82%9.87%1.09%-16.4%4.84%9.35%0.29%1.78%-2.4%-8.07%0.05%-9.24%0.09%0.2%0.18%-36.51%-0.77%0.95%0.67%-3.1%0.12%0%3.16%0%-0.03%7.92%3.52%-1.48%-37.85%0%0%
Net Income3.09B2.68B1.87B2.56B-1.06B-40.16M762.4M748.8M227.36M-222.39M502.96M431.19M532.72M690.62M600.91M-57.23M744.73M881.16M29.02M612.44M797.11M-246.76M164.24M624.79M355.06M184.96M127.23M104.24M74.58M139.25M156.2M
Net Margin %26.93%21.04%16.06%28.17%-21.02%-0.76%14.79%17.92%11.06%-10.61%29.13%28.85%43.17%50.88%42.89%-4.86%60.23%69.34%2.36%36.77%43.3%-14.9%10.47%45.63%38.87%45.15%36.38%38.57%28.63%54.67%52.95%
Net Income Growth %85.64%43.41%-26.97%341.34%-2542.77%-105.27%1.82%229.34%202.24%-144.22%16.64%-19.06%-22.86%14.93%1149.9%-107.69%-15.48%2936.38%-95.26%-23.17%423.03%-250.24%-73.71%75.97%91.97%45.37%22.05%39.78%-46.44%-10.85%-
EPS (Diluted)72.5856.6235.2152.27-25.50-1.5715.3116.295.72-5.5811.439.2812.6014.8711.23-1.1312.3113.40-0.217.9310.57-3.501.858.534.882.722.171.681.112.022.00
EPS Growth %90.77%60.81%-32.64%304.98%-1524.2%-110.25%-6.02%184.79%202.51%-148.82%23.17%-26.35%-15.27%32.41%1093.81%-109.18%-8.13%6480.95%-102.65%-24.98%402%-289.19%-78.31%74.8%79.41%25.35%29.17%51.35%-45.05%1%-
EPS (Basic)-56.7635.3152.40-25.50-1.5715.3416.325.72-5.5811.509.3612.7715.1411.40-1.1312.4213.50-0.218.0810.72-3.501.908.785.082.722.231.701.132.062.05
Diluted Shares Outstanding42.63M44.87M51.34M47.61M43.04M47.17M47.18M43.17M39.76M39.85M41.56M43.53M39.97M44.13M49.6M50.75M55.64M61.21M63.41M71.83M72.06M70.53M71.95M71.04M70.26M62.49M58.72M61.93M67.19M68.94M78.05M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Catastrophe loss volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Volatile Premium Growth Amid Cycles

As reported in financial statements, RenaissanceRe's revenue trajectory remains highly erratic, evidenced by a sharp 36.4% contraction in 2026Q1 following a 117.4% surge in 2024Q3, suggesting that the firm's top-line performance is heavily tethered to the cyclical nature of global reinsurance treaty renewals and catastrophe risk appetite.

The significant quarter-over-quarter revenue swings indicate that RenaissanceRe prioritizes underwriting discipline over consistent premium volume, likely retreating from markets when pricing fails to meet internal hurdle rates. Investors should monitor whether this volatility reflects a strategic pivot toward more selective risk-taking or an inability to maintain market share during competitive pricing environments.

Underwriting Profitability Subject to Shocks

Based on RenaissanceRe's reported figures, the combined ratio has demonstrated extreme sensitivity to loss events, fluctuating from a profitable 53.5% in 2025Q3 to a strained 102.1% in 2025Q1, which highlights the inherent difficulty in maintaining consistent underwriting margins within the property catastrophe reinsurance segment.

The periodic breach of the 100% combined ratio threshold suggests that the company's underwriting performance is frequently disrupted by tail-risk events that overwhelm standard pricing models. This volatility implies that RenaissanceRe's profitability is not a linear function of premium growth but rather a binary outcome dependent on the severity of the annual catastrophe season.

Catastrophe Exposure and Earnings Inflection

According to recent SEC filings, the 2025Q1 period marked a critical inflection point where a 98.2% loss ratio led to a negative operating income of $70.8 million, illustrating the profound impact that concentrated catastrophe exposure can have on the firm's quarterly earnings capacity and overall underwriting efficiency.

This period serves as a stark reminder that RenaissanceRe's earnings profile is susceptible to sudden, sharp reversals when loss activity spikes. The subsequent recovery in later quarters suggests a resilient capital structure, yet it warrants further investigation into whether the firm's risk-modeling software is adequately capturing the increasing frequency of secondary perils.

Structural Risks in Capital Management

As noted in financial disclosures, the reliance on third-party capital vehicles to manage risk creates a complex earnings profile, where the potential for reputational damage and loss of fee income during extreme events may pose a greater threat to shareholder value than direct balance sheet losses alone.

While the third-party capital platform is a key differentiator, it introduces a layer of operational risk that is not fully captured by traditional underwriting metrics. Investors should monitor the potential for conflict between the firm's own balance sheet and its joint venture partners, as any misalignment during a major loss event could jeopardize the sustainability of this fee-based income stream.

RNR — Frequently Asked Questions

Quick answers to the most common questions about buying RNR stock.

What was RenaissanceRe Holdings Ltd.'s (RNR) revenue in 2025?

For fiscal year 2025, RenaissanceRe Holdings Ltd. (RNR) reported total revenue of $12.75B. This represents a 4221.6% increase compared to $295.0M in 1996.

Is RenaissanceRe Holdings Ltd. (RNR) profitable?

RenaissanceRe Holdings Ltd. (RNR) is profitable, generating $2.68B in net income for the fiscal year ending 2025 with a net profit margin of 21.0%.

What is RenaissanceRe Holdings Ltd.'s operating profit margin?

RenaissanceRe Holdings Ltd. (RNR) reported an operating income of $4.01B, resulting in an operating profit margin of 31.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is RenaissanceRe Holdings Ltd.'s gross profit and gross margin?

RenaissanceRe Holdings Ltd. (RNR) generated $5.18B in gross profit for the year, representing a gross profit margin of 40.7%. This demonstrates the company's core pricing power and production efficiency.